Back to search
FDAFDA · Food and drugs·Recall number D-0697-2017

IC-Green (indocyanine green for injection, USP), 25 mg, packaged in a kit containing six vials of 25 mg lyophilized powder, Rx only, Manufactured by: Akorn, Inc., NDC 17478-701-02

Published May 17, 2017 · Recall initiated: April 20, 2017

Summary

FDA records drug Class III recall D-0697-2017, published May 17, 2017 and initiated April 20, 2017. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 1,292 kits; Lot: Kit Lot #031126; Exp 8/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product is being recalled due to low pH value.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide
Lot
Kit Lot #031126; Exp 8/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was IC-Green (indocyanine green for injection, USP), 25 mg, packaged in a kit containing six vials of 25 mg lyophilized powder, Rx only, Manufactured by: Akorn, Inc., NDC 17478-701-02 recalled?

Yes. FDA published recall D-0697-2017 on May 17, 2017. Reported hazard: Product is being recalled due to low pH value.

What should I do if I have this product?

Voluntary: Firm initiated · Letter